Home » Newsletters » BioWorld Science

BioWorld Science

April 6, 2005

View Archived Issues

Anti-RSV agent with a novel mechanism identified

Maxygen earns milestone in alliance with Roche

Dietary DHA could be beneficial for AD

Metabasis updates CS-917 trials status

Potent EAAT2 inhibitors synthesized by Taisho

Tie-2 inhibitor with good in vivo profile effective in a murine model of angiogenesis

Biolipox claims novel antiinflammatory indole compounds

New agents for the treatment of lipoprotein disorders reported by Forbes Medi-Tech

Novel antidiabetic agents imparted by Roche

Clinical trials confirm the good safety profile and low immunogenicity of DX-88

Update on the therapeutic benefits of ciclesonide in asthma

Clinical evidence for the anxiolytic effects of LY-544344

Update: Cancer treatment with Gendicine, the first approved gene therapy

Chugai ceases development of orlistat in Japan

Oncotherapy Science to begin clinical trial for OTS-102

Hemosol to produce iron-binding drugs for Biomedical Frontiers

Hollis-Eden initiates phase I study for Neumune

Critical Therapeutics submits sNDA for Zyflo

Genentech files IND for basal cell carcinoma drug candidate

TAK-187 superior to benznidazole in Chagas' disease model

Migenix receives investment commitment from Technology Partnerships Canada

AnorMED files IND to study AMD-3100 in cardiac patients

Interferon-beta may block viral asthma exacerbations

Alkermes submits Vivitrex NDA

Not approvable letter for cilansetron for IBS-D

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...